AU2001269433A1 - Therapeutic or preventive medicines for mood disorders or anxiety disorders - Google Patents
Therapeutic or preventive medicines for mood disorders or anxiety disordersInfo
- Publication number
- AU2001269433A1 AU2001269433A1 AU2001269433A AU6943301A AU2001269433A1 AU 2001269433 A1 AU2001269433 A1 AU 2001269433A1 AU 2001269433 A AU2001269433 A AU 2001269433A AU 6943301 A AU6943301 A AU 6943301A AU 2001269433 A1 AU2001269433 A1 AU 2001269433A1
- Authority
- AU
- Australia
- Prior art keywords
- disorders
- therapeutic
- anxiety
- mood
- preventive medicines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000-201865 | 2000-07-04 | ||
| JP2000201865 | 2000-07-04 | ||
| PCT/JP2001/005779 WO2002002117A1 (en) | 2000-07-04 | 2001-07-04 | Therapeutic or preventive medicines for mood disorders or anxiety disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001269433A1 true AU2001269433A1 (en) | 2002-01-14 |
Family
ID=18699472
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001269433A Abandoned AU2001269433A1 (en) | 2000-07-04 | 2001-07-04 | Therapeutic or preventive medicines for mood disorders or anxiety disorders |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1300145A4 (en) |
| CN (1) | CN1440286A (en) |
| AU (1) | AU2001269433A1 (en) |
| CA (1) | CA2414971A1 (en) |
| WO (1) | WO2002002117A1 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4939259A (en) * | 1989-07-24 | 1990-07-03 | Eli Lilly And Company | 2-oxo-pyrido[2,3-g]quinoline derivatives |
| JP2985322B2 (en) * | 1991-03-01 | 1999-11-29 | 東レ株式会社 | Isoquinoline derivatives and their pharmaceutical uses |
| US6103722A (en) * | 1997-07-23 | 2000-08-15 | The Medical College Of Wisconsin Research Foundation Inc. | Ischemic preconditioning |
| EP1234828A4 (en) * | 1999-11-30 | 2005-01-12 | Toray Industries | Agents for improving learning or memory |
-
2001
- 2001-07-04 AU AU2001269433A patent/AU2001269433A1/en not_active Abandoned
- 2001-07-04 CA CA002414971A patent/CA2414971A1/en not_active Abandoned
- 2001-07-04 WO PCT/JP2001/005779 patent/WO2002002117A1/en not_active Application Discontinuation
- 2001-07-04 EP EP01947800A patent/EP1300145A4/en not_active Withdrawn
- 2001-07-04 CN CN01812401A patent/CN1440286A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN1440286A (en) | 2003-09-03 |
| CA2414971A1 (en) | 2002-12-31 |
| EP1300145A4 (en) | 2004-07-07 |
| EP1300145A1 (en) | 2003-04-09 |
| WO2002002117A1 (en) | 2002-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL157734A0 (en) | Pharmaceutical compositions for the treatment of urogenital disorders | |
| ZA200401004B (en) | Combination for the treatment of inflammatory disorders | |
| PL373626A1 (en) | Treatment for central nervous system disorders | |
| IL153425A0 (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders | |
| GB0007193D0 (en) | Treatment of movrmrnt disorders | |
| IL150742A0 (en) | Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease | |
| ZA200309627B (en) | Compounds for the treatment of metabolic disorders | |
| AU2002211612A1 (en) | Methods for the treatment of a traumatic central nervous system injury | |
| IL162485A0 (en) | Compounds for the treatment of inflammatory disorders | |
| AU2002334870B8 (en) | Combinations for the treatment of immunoinflammatory disorders | |
| IL155589A0 (en) | Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | |
| AU6910600A (en) | Methods for the treatment of mental disorders | |
| IL150289A0 (en) | Drug combination for the treatment of depression and related disorders comprising mirtazapine | |
| MXPA03004190A (en) | Treatment of anxiety disorders. | |
| IL160852A0 (en) | Pharmaceutical compositions for the treatment of urinary disorders | |
| EP1331010A4 (en) | Preventives and remedies for central nervous system diseases | |
| IL154378A0 (en) | Compounds for the treatment of addictive disorders | |
| AU2002258798A1 (en) | Methods for the treatment of hepatic disorders | |
| AU2001269433A1 (en) | Therapeutic or preventive medicines for mood disorders or anxiety disorders | |
| HRP20041159A2 (en) | Combination for the treatment of airway disorders | |
| AU2002338849A1 (en) | Pharmaceutical composition for the treatment of disorders of non-human mammals | |
| AUPQ696900A0 (en) | Novel therapy for hyperlipidaemia-associated disorders | |
| AUPR085100A0 (en) | Novel therapy for hyperlipidaemia-associated disorders | |
| AU2002322397A1 (en) | Combination therapy for the treatment of neurological disorders | |
| AU2002338555A1 (en) | Sreenint for drugs for reduction of anxiety |